| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A comparison of trends in mortality from primary liver cancer and intrahepatic cholangiocarcinoma in Europe
|
Bertuccio, P.
|
|
|
24 |
6 |
p. 1667-1674
|
artikel
|
| 2 |
Adherence to treatment guidelines for primary sarcomas affects patient survival: a side study of the European CONnective TIssue CAncer NETwork (CONTICANET)
|
Rossi, C.R.
|
|
|
24 |
6 |
p. 1685-1691
|
artikel
|
| 3 |
A phase II multicenter trial of hyperCVAD MTX/Ara-C and rituximab in patients with previously untreated mantle cell lymphoma; SWOG 0213
|
Bernstein, S.H.
|
|
|
24 |
6 |
p. 1587-1593
|
artikel
|
| 4 |
A randomized, controlled trial of acupuncture self-needling as maintenance therapy for cancer-related fatigue after therapist-delivered acupuncture
|
Molassiotis, A.
|
|
|
24 |
6 |
p. 1645-1652
|
artikel
|
| 5 |
A randomized phase II study of PEP02 (MM-398), irinotecan or docetaxel as a second-line therapy in patients with locally advanced or metastatic gastric or gastro-oesophageal junction adenocarcinoma †
|
Roy, A.C.
|
|
|
24 |
6 |
p. 1567-1573
|
artikel
|
| 6 |
Aromatase inhibitor-induced arthralgia: a review
|
Niravath, P.
|
|
|
24 |
6 |
p. 1443-1449
|
artikel
|
| 7 |
Aromatase inhibitors induce ‘male pattern hair loss’ in women?
|
Rossi, A.
|
|
|
24 |
6 |
p. 1710-1711
|
artikel
|
| 8 |
Bevacizumab use and risk of cardiovascular adverse events among elderly patients with colorectal cancer receiving chemotherapy: a population-based study
|
Tsai, H.-T.
|
|
|
24 |
6 |
p. 1574-1579
|
artikel
|
| 9 |
Breast cancer survivors of different sexual orientations: which factors explain survivors' quality of life and adjustment?
|
Boehmer, U.
|
|
|
24 |
6 |
p. 1622-1630
|
artikel
|
| 10 |
Cancer prevalence estimates in Europe at the beginning of 2000
|
Gatta, G.
|
|
|
24 |
6 |
p. 1660-1666
|
artikel
|
| 11 |
Capecitabine/irinotecan or capecitabine/oxaliplatin in combination with bevacizumab is effective and safe as first-line therapy for metastatic colorectal cancer: a randomized phase II study of the AIO colorectal study group
|
Schmiegel, W.
|
|
|
24 |
6 |
p. 1580-1587
|
artikel
|
| 12 |
Clinical outcomes and safety with trabectedin therapy in patients with advanced soft tissue sarcomas following failure of prior chemotherapy: results of a worldwide expanded access program study †
|
Samuels, B.L.
|
|
|
24 |
6 |
p. 1703-1709
|
artikel
|
| 13 |
CYP2C8*3 increases risk of neuropathy in breast cancer patients treated with paclitaxel †
|
Hertz, D.L.
|
|
|
24 |
6 |
p. 1472-1478
|
artikel
|
| 14 |
Dental diagnostic X-ray exposure and risk of benign and malignant brain tumors
|
Lin, M.C.
|
|
|
24 |
6 |
p. 1675-1679
|
artikel
|
| 15 |
Dietary patterns and gastric cancer risk: a systematic review and meta-analysis
|
Bertuccio, P.
|
|
|
24 |
6 |
p. 1450-1458
|
artikel
|
| 16 |
Editorial board
|
|
|
|
24 |
6 |
p. ii-iii
|
artikel
|
| 17 |
Evaluation of fat grafting safety in patients with intra epithelial neoplasia: a matched-cohort study
|
Petit, J.Y.
|
|
|
24 |
6 |
p. 1479-1484
|
artikel
|
| 18 |
Experience in daily practice with ipilimumab for the treatment of patients with metastatic melanoma: an early increase in lymphocyte and eosinophil counts is associated with improved survival
|
Delyon, J.
|
|
|
24 |
6 |
p. 1697-1703
|
artikel
|
| 19 |
Extended pelvic lymph node dissection in prostate cancer: a 20-year audit in a single center
|
Abdollah, F.
|
|
|
24 |
6 |
p. 1459-1466
|
artikel
|
| 20 |
Extended pelvic lymph node dissection in prostate cancer: a 20-year audit in a single center
|
Riggs, S.
|
|
|
24 |
6 |
p. 1423-1424
|
artikel
|
| 21 |
Families' experiences with patients who died after assisted suicide: a retrospective interview study in southern Switzerland
|
Gamondi, C.
|
|
|
24 |
6 |
p. 1639-1644
|
artikel
|
| 22 |
Genetic variability in the multidrug resistance associated protein-1 (ABCC1/MRP1) predicts hematological toxicity in breast cancer patients receiving (neo-)adjuvant chemotherapy with 5-fluorouracil, epirubicin and cyclophosphamide (FEC)
|
Vulsteke, C.
|
|
|
24 |
6 |
p. 1513-1525
|
artikel
|
| 23 |
Identifying the target NSCLC patient for maintenance therapy: an analysis from a placebo-controlled, phase III trial of maintenance pemetrexed (H3E-MC-JMEN) †
|
Obasaju, C.
|
|
|
24 |
6 |
p. 1534-1542
|
artikel
|
| 24 |
Impact of a donor source on adult Philadelphia chromosome-negative acute lymphoblastic leukemia: a retrospective analysis from the Adult Acute Lymphoblastic Leukemia Working Group of the Japan Society for Hematopoietic Cell Transplantation
|
Nishiwaki, S.
|
|
|
24 |
6 |
p. 1594-1602
|
artikel
|
| 25 |
Incidence and risk of central nervous system metastases as site of first recurrence in patients with HER2-positive breast cancer treated with adjuvant trastuzumab
|
Olson, E.M.
|
|
|
24 |
6 |
p. 1526-1533
|
artikel
|
| 26 |
Locoregional recurrence of early-stage surgically resected non-small-cell lung cancer: the importance of close follow-up and consistent definitions
|
Varlotto, J.
|
|
|
24 |
6 |
p. 1711-1712
|
artikel
|
| 27 |
Long-term clinical and molecular remissions in patients with follicular lymphoma following high-dose therapy and autologous stem cell transplantation
|
Metzner, B.
|
|
|
24 |
6 |
p. 1609-1615
|
artikel
|
| 28 |
Long-term survival results of a randomized phase III trial of vinflunine plus best supportive care versus best supportive care alone in advanced urothelial carcinoma patients after failure of platinum-based chemotherapy †
|
Bellmunt, J.
|
|
|
24 |
6 |
p. 1466-1472
|
artikel
|
| 29 |
Male breast cancer: risk factors, biology, diagnosis, treatment, and survivorship
|
Ruddy, K.J.
|
|
|
24 |
6 |
p. 1434-1443
|
artikel
|
| 30 |
Multicentre phase II study of cisplatin–etoposide chemotherapy for advanced large-cell neuroendocrine lung carcinoma: the GFPC 0302 study
|
Le Treut, J.
|
|
|
24 |
6 |
p. 1548-1552
|
artikel
|
| 31 |
Multicentre phase II trial of bevacizumab combined with docetaxel–carboplatin for the neoadjuvant treatment of triple-negative breast cancer (KCSG BR-0905)
|
Kim, H.R.
|
|
|
24 |
6 |
p. 1485-1490
|
artikel
|
| 32 |
Needs regarding care and factors associated with unmet needs in disease-free survivors of surgically treated lung cancer
|
Yun, Y.H.
|
|
|
24 |
6 |
p. 1552-1559
|
artikel
|
| 33 |
Outcome of patients with transformed indolent non-Hodgkin lymphoma referred for autologous stem-cell transplantation
|
Villa, D.
|
|
|
24 |
6 |
p. 1603-1609
|
artikel
|
| 34 |
Prevention of chemotherapy-induced peripheral neuropathy: a matter of personalized treatment?
|
Postma, T.J.
|
|
|
24 |
6 |
p. 1424-1426
|
artikel
|
| 35 |
Promoter methylation of BRCA1 in triple-negative breast cancer predicts sensitivity to adjuvant chemotherapy
|
Xu, Y.
|
|
|
24 |
6 |
p. 1498-1505
|
artikel
|
| 36 |
Prospective analysis of quality of life in elderly patients treated with adjuvant chemotherapy for non-small-cell lung cancer
|
Park, S.
|
|
|
24 |
6 |
p. 1630-1639
|
artikel
|
| 37 |
Prospective evaluation of type 2 diabetes mellitus on the risk of primary liver cancer in Chinese men and women
|
Yang, W.S.
|
|
|
24 |
6 |
p. 1679-1685
|
artikel
|
| 38 |
Prospective study of cutaneous side-effects associated with the BRAF inhibitor vemurafenib: a study of 42 patients
|
Boussemart, L.
|
|
|
24 |
6 |
p. 1691-1697
|
artikel
|
| 39 |
Quality of life (QoL) analyses from OPTIMAL (CTONG-0802), a phase III, randomised, open-label study of first-line erlotinib versus chemotherapy in patients with advanced EGFR mutation-positive non-small-cell lung cancer (NSCLC)
|
Chen, G.
|
|
|
24 |
6 |
p. 1615-1622
|
artikel
|
| 40 |
Regorafenib in combination with FOLFOX or FOLFIRI as first- or second-line treatment of colorectal cancer: results of a multicenter, phase Ib study
|
Schultheis, B.
|
|
|
24 |
6 |
p. 1560-1567
|
artikel
|
| 41 |
Stage I–II non-small-cell lung cancer treated using either stereotactic ablative radiotherapy (SABR) or lobectomy by video-assisted thoracoscopic surgery (VATS): outcomes of a propensity score-matched analysis
|
Verstegen, N.E.
|
|
|
24 |
6 |
p. 1543-1548
|
artikel
|
| 42 |
Statins and prostate cancer recurrence following radical prostatectomy or radiotherapy: a systematic review and meta-analysis
|
Park, H.S.
|
|
|
24 |
6 |
p. 1427-1434
|
artikel
|
| 43 |
Table of Contents
|
|
|
|
24 |
6 |
p. iv-vii
|
artikel
|
| 44 |
Tetrathiomolybdate-associated copper depletion decreases circulating endothelial progenitor cells in women with breast cancer at high risk of relapse
|
Jain, S.
|
|
|
24 |
6 |
p. 1491-1498
|
artikel
|
| 45 |
The effect of CYP2C19 polymorphism on the safety, tolerability, and pharmacokinetics of tivantinib (ARQ 197): results from a phase I trial in advanced solid tumors
|
Yamamoto, N.
|
|
|
24 |
6 |
p. 1653-1659
|
artikel
|
| 46 |
The Patient's Anastrozole Compliance to Therapy (PACT) Program: a randomized, in-practice study on the impact of a standardized information program on persistence and compliance to adjuvant endocrine therapy in postmenopausal women with early breast cancer †
|
Hadji, P.
|
|
|
24 |
6 |
p. 1505-1512
|
artikel
|
| 47 |
Urgent treatment of patients with metastatic melanoma using braf inhibitors in the absence of braf mutation status
|
Nathan, P.
|
|
|
24 |
6 |
p. 1712-1713
|
artikel
|
Tijdschrift beschrijving